eHealth: Individualization of Mesalazine Treatment Through a Self-managed Web-based Solution in Mild-to-moderate Ulcerative Colitis

• Published in: Inflammatory bowel diseases Vol. 20; no. 12; pp. 2276 - 2285
• Main Authors: Pedersen, Natalia, Thielsen, Peter, Martinsen, Lars, Bennedsen, Mette, Haaber, Anne, Langholz, Ebbe, Végh, Zsuzsanna, Duricova, Dana, Jess, Tine, Bell, Sally, Burisch, Johan, Munkholm, Pia
• Format: Journal Article
• Language: English
• Published: Oxford, UK Oxford University Press 01.12.2014
• Subjects: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use; Colitis, Ulcerative - drug therapy; Colitis, Ulcerative - psychology; Computer-Assisted Instruction; Drug Administration Schedule; Female; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Humans; Inflammatory bowel disease; Internet; Male; Medication Adherence; Mesalamine - therapeutic use; Middle Aged; Patient Education as Topic; Precision Medicine; Prognosis; Prospective Studies; Quality of Life; Recurrence; Self Care; Severity of Illness Index; Telemedicine; Young Adult; mesalazine; ulcerative colitis; multimatrix system; inflammatory bowel disease; web-based management

To individualize treatment with mesalazine for ulcerative colitis relapses through a self-managed, web-based solution to optimize the short-term disease course.MethodsProspective, open-label, web-guided study with 3 months mesalazine therapy among patients with mild-to-moderate ulcerative colitis. O...